Abalos Therapeutics GmbH

2 trials 1 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

2 Countries active

0 Unique IMPs

N/A Results reported

Phase I

All trials

2 total

A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr… Not authorised

2024-512403-39-00 Phase I 2 countries
A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr… Recruiting

2024-512403-39-01 Phase I 2 countries

Showing 1–2 of 2 trials

← All sponsors A–Z